
Melody Noel Brown
Examiner (ID: 8663, Phone: (571)272-2599 , Office: P/2917 )
| Most Active Art Unit | 2917 |
| Art Unit(s) | 2915, 2901, 2917, 2911 |
| Total Applications | 11867 |
| Issued Applications | 11761 |
| Pending Applications | 2 |
| Abandoned Applications | 102 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20241006
[patent_doc_number] => 12421314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Binding molecules specific for fcgRIIA and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/350267
[patent_app_country] => US
[patent_app_date] => 2023-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 35
[patent_no_of_words] => 19912
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350267
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/350267 | Binding molecules specific for fcgRIIA and uses thereof | Jul 10, 2023 | Issued |
Array
(
[id] => 20115061
[patent_doc_number] => 12364745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Immunogenicity of a CpG-adjuvanted recombinant plague vaccine
[patent_app_type] => utility
[patent_app_number] => 18/344780
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10641
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18344780
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/344780 | Immunogenicity of a CpG-adjuvanted recombinant plague vaccine | Jun 28, 2023 | Issued |
Array
(
[id] => 19150156
[patent_doc_number] => 11975046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Medical use of interferon-lambda for the treatment of fibrosis
[patent_app_type] => utility
[patent_app_number] => 18/343944
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 50
[patent_no_of_words] => 16279
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18343944
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/343944 | Medical use of interferon-lambda for the treatment of fibrosis | Jun 28, 2023 | Issued |
Array
(
[id] => 18752482
[patent_doc_number] => 20230355735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => GLYCOCONJUGATION PROCESSES AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/338961
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338961
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338961 | Glycoconjugation processes and compositions | Jun 20, 2023 | Issued |
Array
(
[id] => 18692572
[patent_doc_number] => 20230322871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => EXPRESSION OF PNEUMOCOCCAL SURFACE PROTEIN A (PSPA)
[patent_app_type] => utility
[patent_app_number] => 18/338584
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338584
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338584 | EXPRESSION OF PNEUMOCOCCAL SURFACE PROTEIN A (PSPA) | Jun 20, 2023 | Pending |
Array
(
[id] => 19447405
[patent_doc_number] => 20240307535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => ANTI-LAM AND ANTI-PIM6/LAM MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/335489
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335489
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335489 | Anti-LAM and anti-PIM6/LAM monoclonal antibodies for diagnosis and treatment of | Jun 14, 2023 | Issued |
Array
(
[id] => 18902979
[patent_doc_number] => 20240018464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => GENETICALLY MODIFIED HAPLOID ISSATCHENKIA ORIENTALIS
[patent_app_type] => utility
[patent_app_number] => 18/335717
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335717
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335717 | Genetically modified haploid | Jun 14, 2023 | Issued |
Array
(
[id] => 20491529
[patent_doc_number] => 12533384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/335248
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 980
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18335248
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/335248 | None | Jun 14, 2023 | Issued |
Array
(
[id] => 18985643
[patent_doc_number] => 20240057612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => Combinations of Yersinia Entomophaga and Pesticides or Other Substances
[patent_app_type] => utility
[patent_app_number] => 18/331298
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18331298
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/331298 | Combinations of | Jun 7, 2023 | Issued |
Array
(
[id] => 18829673
[patent_doc_number] => 20230398197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN
[patent_app_type] => utility
[patent_app_number] => 18/329816
[patent_app_country] => US
[patent_app_date] => 2023-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18329816
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/329816 | COLDWATER DISEASE VACCINE COMPRISING AN ATTENUATED FLAVOBACTERIUM PSYCHROPHILUM STRAIN | Jun 5, 2023 | Abandoned |
Array
(
[id] => 19792197
[patent_doc_number] => 12233120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Proteins and immunizing compositions containing
[patent_app_type] => utility
[patent_app_number] => 18/203917
[patent_app_country] => US
[patent_app_date] => 2023-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 26797
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18203917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/203917 | Proteins and immunizing compositions containing | May 30, 2023 | Issued |
Array
(
[id] => 18610908
[patent_doc_number] => 20230277638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => SOUTHERN CATTLE TICK VACCINE PRODUCT
[patent_app_type] => utility
[patent_app_number] => 18/318909
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18318909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/318909 | Southern cattle tick vaccine product | May 16, 2023 | Issued |
Array
(
[id] => 18842632
[patent_doc_number] => 20230405036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => A NEW STREPTOMYCES SPORORAVEUS STRAIN AND A NEW ANTIBIOTICS AGAINST BACTERIA AND FUNGI
[patent_app_type] => utility
[patent_app_number] => 18/319312
[patent_app_country] => US
[patent_app_date] => 2023-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18319312
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/319312 | None | May 16, 2023 | Issued |
Array
(
[id] => 19096460
[patent_doc_number] => 20240115687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => Attenuating bacterial virulence by attenuating bacterial folate transport
[patent_app_type] => utility
[patent_app_number] => 18/316499
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316499
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316499 | Attenuating bacterial virulence by attenuating bacterial folate transport | May 11, 2023 | Issued |
Array
(
[id] => 18724357
[patent_doc_number] => 20230338499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => POLYPEPTIDES OF FUSOBACTERIUM AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/144568
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18144568
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/144568 | Polypeptides of fusobacterium and methods of use | May 7, 2023 | Issued |
Array
(
[id] => 19098194
[patent_doc_number] => 20240117422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => MUTANT PORE
[patent_app_type] => utility
[patent_app_number] => 18/313079
[patent_app_country] => US
[patent_app_date] => 2023-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313079
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313079 | Mutant pore | May 4, 2023 | Issued |
Array
(
[id] => 18739585
[patent_doc_number] => 20230348542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => ULTRASMALL GAS-FILLED PROTEIN NANOSTRUCTURES
[patent_app_type] => utility
[patent_app_number] => 18/310512
[patent_app_country] => US
[patent_app_date] => 2023-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18310512
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/310512 | ULTRASMALL GAS-FILLED PROTEIN NANOSTRUCTURES | Apr 30, 2023 | Pending |
Array
(
[id] => 18707624
[patent_doc_number] => 20230330201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/309555
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11199
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/309555 | COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS | Apr 27, 2023 | Abandoned |
Array
(
[id] => 18673049
[patent_doc_number] => 20230310521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING
[patent_app_type] => utility
[patent_app_number] => 18/191328
[patent_app_country] => US
[patent_app_date] => 2023-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26386
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18191328
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/191328 | COMBINATION COMPRISING BACILLUS AND AN ESSENTIAL OIL AND METHODS FOR MAKING AND USING | Mar 27, 2023 | Abandoned |
Array
(
[id] => 20057409
[patent_doc_number] => 20250195631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER
[patent_app_type] => utility
[patent_app_number] => 18/851628
[patent_app_country] => US
[patent_app_date] => 2023-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18851628
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/851628 | ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER | Mar 27, 2023 | Pending |